Lucio Mendes Cabral

No ORCID on file · 3 papers in corpus · active 2015-2022

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 3
  • mesh:D004715 2
article 2022
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph15111414

Background: Current drugs for the treatment of endometriosis are not able to completely cure the condition, and significant side effects hinder the continuation of treatment. Therefore, it is necessary to search for new drug candidates. In …

other 2018
Pharmaceutical development and technology ·doi:10.1080/10837450.2017.1290107

Copaiba oleoresin (CPO), obtained from Copaifera landgroffii, is described as active to a large number of diseases and more recently in the endometriosis treatment. In this work, poly(lactic-co-glycolic acid) (PLGA) nanoparticles containing…

article 2015
The Journal of pharmacy and pharmacology ·doi:10.1111/jphp.12479

OBJECTIVES: The hormonal treatment for endometriosis frequently fails to completely eradicate endometriotic implants. A new therapeutic treatment is needed. This study investigates the in-vitro effect of Copaifera langsdorffii oil-resin on …